MedWatch

Head of research at Novo steps down after 17 years in the office

Novo Nordisk's long-term Senior Vice President of Global Research Peter Kurtzhals has decided to step down from the position he has held for 17 years. It happens due to health reasons and triggers a number of changes in the organization.

Peter Kurtzhals, direktør for diabetesforskningen i Novo Nordisk
Peter Kurtzhals, Senior Vice President of Global Research at Novo Nordisk, steps down effective immediately from his current position after 17 years. He will stay in the organization, but in a different capacity.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Takeda nedlægger 100 stillinger i Danmark

Et ønske om at centralisere de globale funktioner i medicinalselskabet Takeda rammer selskabets danske afdeling, hvor omkring 100 stillinger - mere end halvdelen - vil blive skåret, når funktioner rykkes ud af landet.

Shire afviser gigantisk milliardbud fra Takeda

Den japanske medicinalkoncern Takeda bekræfter rygter i flere internationale medier om, at man har budt omkring 370 mia. kr. på Shire, men oplyser samtidig, at buddet er blevet afvist. Shire bekræfter også og siger, at tilbuddet "væsentlig undervurderer" selskabets værdi.

Related articles